Morgan Stanley
ONCR

Morgan Stanley’s Oncorus, Inc. ONCR Stock Holding History

Morgan Stanley’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,506
Closed -$1.55K – 7756
2023
Q1 		$1.55K Sell
4,506
-3,888
-46% -$1.45K ﹤0.01% 7284
2022
Q4 		$2.13K Sell
8,394
-6,995
-45% -$3.98K ﹤0.01% 7358
2022
Q3 		$13K Sell
15,389
-28,109
-65% -$36.1K ﹤0.01% 6993
2022
Q2 		$55K Sell
43,498
-37,312
-46% -$50.7K ﹤0.01% 6572
2022
Q1 		$143K Sell
80,810
-34,952
-30% -$97.9K ﹤0.01% 6105
2021
Q4 		$611K Buy
115,762
+38,565
+50% +$299K ﹤0.01% 5423
2021
Q3 		$721K Buy
77,197
+67,511
+697% +$770K ﹤0.01% 5278
2021
Q2 		$134K Sell
9,686
-183,212
-95% -$2.83M ﹤0.01% 6211
2021
Q1 		$2.69M Buy
192,898
+185,768
+2,605% +$3.85M ﹤0.01% 4026
2020
Q4 		$230K Buy
+7,130
New +$165K ﹤0.01% 5526

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $328M AUM 19.81% 1-Year Est. Return